Literature DB >> 7626961

Cerebral metabolic change in patients with AIDS: report of a six-month follow-up using positron-emission tomography.

C H Hinkin1, W G van Gorp, M A Mandelkern, M Gee, P Satz, S Holston, T D Marcotte, G Evans, D H Paz, J R Ropchan.   

Abstract

The authors examined change in cerebral metabolic function over time by using PET in HIV-infected individuals diagnosed with AIDS. Ten subjects with AIDS received [18F]2-fluoro-2-deoxy-D-glucose PET scans and completed a comprehensive neuropsychological battery. The scan and test battery were repeated after 6 months. Over time, the subjects showed increased relative basal ganglia metabolism as well as increased parietal lobe metabolism. There were no statistically significant changes in neuropsychological performance. These results suggest that PET may be more sensitive than traditional neuropsychological evaluation to subtle central nervous system changes in AIDS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626961     DOI: 10.1176/jnp.7.2.180

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  28 in total

Review 1.  The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

Authors:  David F Tate; Rola Khedraki; Daniel McCaffrey; Daniel Branson; Jeffrey Dewey
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Increased subcortical neural activity among HIV+ individuals during a lexical retrieval task.

Authors:  April D Thames; Philip Sayegh; Kevin Terashima; Jessica M Foley; Andrew Cho; Alyssa Arentoft; Charles H Hinkin; Susan Y Bookheimer
Journal:  Neurobiol Dis       Date:  2015-10-17       Impact factor: 5.996

Review 3.  Neuropsychiatric aspects of HIV infection among older adults.

Authors:  C H Hinkin; S A Castellon; J H Atkinson; K Goodkin
Journal:  J Clin Epidemiol       Date:  2001-12       Impact factor: 6.437

4.  Increased Cortical Cerebral Blood Flow in Asymptomatic Human Immunodeficiency Virus-Infected Subjects.

Authors:  Souvik Sen; Hongyu An; Prema Menezes; Jonathan Oakes; Joseph Eron; Weili Lin; Kevin Robertson; William Powers
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-05-05       Impact factor: 2.136

Review 5.  Brain PET Imaging: Value for Understanding the Pathophysiology of HIV-associated Neurocognitive Disorder (HAND).

Authors:  Sanhita Sinharay; Dima A Hammoud
Journal:  Curr HIV/AIDS Rep       Date:  2019-02       Impact factor: 5.071

6.  Progressive brain atrophy in chronically infected and treated HIV+ individuals.

Authors:  Talia M Nir; Neda Jahanshad; Christopher R K Ching; Ronald A Cohen; Jaroslaw Harezlak; Giovanni Schifitto; Hei Y Lam; Xue Hua; Jianhui Zhong; Tong Zhu; Michael J Taylor; Thomas B Campbell; Eric S Daar; Elyse J Singer; Jeffry R Alger; Paul M Thompson; Bradford A Navia
Journal:  J Neurovirol       Date:  2019-02-14       Impact factor: 2.643

Review 7.  Role of nuclear medicine in neuroHIV: PET, SPECT, and beyond.

Authors:  Mike Sathekge; Alicia McFarren; Ekaterina Dadachova
Journal:  Nucl Med Commun       Date:  2014-08       Impact factor: 1.690

Review 8.  Neuroimaging of HIV-associated neurocognitive disorders (HAND).

Authors:  Beau M Ances; Dima A Hammoud
Journal:  Curr Opin HIV AIDS       Date:  2014-11       Impact factor: 4.283

Review 9.  Positron emission tomography in patients suffering from HIV-1 infection.

Authors:  Mike Sathekge; Ingeborg Goethals; Alex Maes; Christophe van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-07       Impact factor: 9.236

10.  Neurocognition in individuals co-infected with HIV and hepatitis C.

Authors:  Charles H Hinkin; Steven A Castellon; Andrew J Levine; Terry R Barclay; Elyse J Singer
Journal:  J Addict Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.